ZOETIS INC. (ZTS)
$
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
About
Business overview of ZOETIS INC. (ZTS)
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on), and nearly 65% from companion animal (dogs, horses, cats) products. Its us business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Key Insights
Critical company metrics and information
Share Price
$177.58Market Cap
$80.12 BillionTotal Outstanding Shares
451.17 Million SharesTotal Employees
14,100Dividend
$0.432 Per Share QuarterlyIPO Date
February 1, 2013SIC Description
Pharmaceutical PreparationsHomepage
https://www.zoetis.com
Historical Stock Splits
Execution Date | Split Amount |
---|---|
No Historical Stock Splits |
Cash Flow Statement
October 1, 2023 to September 30, 2024
Metric | Value |
---|---|
Exchange Gains/Losses | $-22.00 Million |
Net Cash Flow, Continuing | $-18.00 Million |
Net Cash Flow From Operating Activities | $2.94 Billion |
Net Cash Flow From Investing Activities | $-651.00 Million |
Net Cash Flow From Operating Activities, Continuing | $2.94 Billion |
Net Cash Flow From Financing Activities | $-2.31 Billion |
Net Cash Flow From Investing Activities, Continuing | $-651.00 Million |
Net Cash Flow | $-40.00 Million |
Net Cash Flow From Financing Activities, Continuing | $-2.31 Billion |
Income Statement
October 1, 2023 to September 30, 2024
Metric | Value |
---|---|
Selling, General, and Administrative Expenses | $2.26 Billion |
Basic Average Shares | $1.37 Billion |
Operating Expenses | $3.36 Billion |
Basic Earnings Per Share | $5.33 |
Revenues | $9.15 Billion |
Net Income/Loss | $2.44 Billion |
Income Tax Expense/Benefit, Deferred | $-207.00 Million |
Income/Loss From Continuing Operations Before Tax | $3.05 Billion |
Costs And Expenses | $6.10 Billion |
Net Income/Loss Available To Common Stockholders, Basic | $2.43 Billion |
Diluted Average Shares | $1.37 Billion |
Net Income/Loss Attributable To Noncontrolling Interest | $8.00 Million |
Nonoperating Income/Loss | $7.00 Million |
Operating Income/Loss | $3.05 Billion |
Cost Of Revenue | $2.74 Billion |
Net Income/Loss Attributable To Parent | $2.43 Billion |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
Interest Expense, Operating | $233.00 Million |
Income/Loss From Continuing Operations After Tax | $2.44 Billion |
Other Operating Expenses | $1.10 Billion |
Benefits Costs and Expenses | $6.10 Billion |
Preferred Stock Dividends And Other Adjustments | $0.00 |
Gross Profit | $6.41 Billion |
Income Tax Expense/Benefit | $613.00 Million |
Diluted Earnings Per Share | $5.32 |
Balance Sheet
October 1, 2023 to September 30, 2024
Metric | Value |
---|---|
Current Liabilities | $1.70 Billion |
Liabilities | $9.12 Billion |
Inventory | $2.42 Billion |
Other Current Assets | $3.87 Billion |
Equity Attributable To Noncontrolling Interest | $0.00 |
Liabilities And Equity | $14.36 Billion |
Accounts Payable | $404.00 Million |
Current Assets | $6.28 Billion |
Wages | $335.00 Million |
Intangible Assets | $1.19 Billion |
Assets | $14.36 Billion |
Fixed Assets | $3.30 Billion |
Other Current Liabilities | $963.00 Million |
Noncurrent Assets | $8.07 Billion |
Equity | $5.23 Billion |
Equity Attributable To Parent | $5.23 Billion |
Noncurrent Liabilities | $7.42 Billion |
Other Non-current Assets | $3.59 Billion |
Historical Dividends
Current dividend: $0.432 Per Share Quarterly
Announcement Date | Payment Date | Record Date | Amount | Frequency |
---|---|---|---|---|
Oct 10, 2024 | Dec 3, 2024 | Oct 31, 2024 | $0.432 | Quarterly |
May 22, 2024 | Sep 4, 2024 | Jul 18, 2024 | $0.432 | Quarterly |
Feb 6, 2024 | Jun 4, 2024 | Apr 19, 2024 | $0.432 | Quarterly |
Dec 7, 2023 | Mar 1, 2024 | Jan 19, 2024 | $0.432 | Quarterly |
Oct 12, 2023 | Dec 1, 2023 | Nov 1, 2023 | $0.375 | Quarterly |
May 11, 2023 | Sep 1, 2023 | Jul 21, 2023 | $0.375 | Quarterly |
Feb 8, 2023 | Jun 1, 2023 | Apr 21, 2023 | $0.375 | Quarterly |
Dec 8, 2022 | Mar 1, 2023 | Jan 20, 2023 | $0.375 | Quarterly |
Oct 13, 2022 | Dec 1, 2022 | Nov 1, 2022 | $0.325 | Quarterly |
May 19, 2022 | Sep 1, 2022 | Jul 21, 2022 | $0.325 | Quarterly |
Feb 8, 2022 | Jun 1, 2022 | Apr 21, 2022 | $0.325 | Quarterly |
Dec 7, 2021 | Mar 1, 2022 | Jan 20, 2022 | $0.325 | Quarterly |
Oct 14, 2021 | Dec 1, 2021 | Oct 29, 2021 | $0.25 | Quarterly |
May 20, 2021 | Sep 1, 2021 | Jul 21, 2021 | $0.25 | Quarterly |
Feb 10, 2021 | Jun 1, 2021 | Apr 21, 2021 | $0.25 | Quarterly |
Dec 9, 2020 | Mar 1, 2021 | Jan 20, 2021 | $0.25 | Quarterly |
Oct 7, 2020 | Dec 1, 2020 | Oct 21, 2020 | $0.2 | Quarterly |
May 20, 2020 | Sep 1, 2020 | Jul 17, 2020 | $0.2 | Quarterly |
Feb 11, 2020 | Jun 1, 2020 | Apr 17, 2020 | $0.2 | Quarterly |
Dec 11, 2019 | Mar 3, 2020 | Jan 17, 2020 | $0.2 | Quarterly |
Oct 3, 2019 | Dec 2, 2019 | Oct 22, 2019 | $0.164 | Quarterly |
May 15, 2019 | Sep 3, 2019 | Jul 19, 2019 | $0.164 | Quarterly |
Feb 12, 2019 | Jun 3, 2019 | Apr 18, 2019 | $0.164 | Quarterly |
Dec 12, 2018 | Mar 1, 2019 | Jan 18, 2019 | $0.164 | Quarterly |
Oct 10, 2018 | Dec 3, 2018 | Nov 20, 2018 | $0.126 | Quarterly |
May 15, 2018 | Sep 4, 2018 | Jul 20, 2018 | $0.126 | Quarterly |
Feb 13, 2018 | Jun 1, 2018 | Apr 20, 2018 | $0.126 | Quarterly |
Dec 11, 2017 | Mar 1, 2018 | Jan 19, 2018 | $0.126 | Quarterly |
Oct 5, 2017 | Dec 1, 2017 | Nov 9, 2017 | $0.105 | Quarterly |
May 11, 2017 | Sep 1, 2017 | Jun 15, 2017 | $0.105 | Quarterly |
Feb 14, 2017 | Jun 1, 2017 | Apr 6, 2017 | $0.105 | Quarterly |
Dec 6, 2016 | Mar 1, 2017 | Jan 20, 2017 | $0.105 | Quarterly |
Oct 6, 2016 | Dec 1, 2016 | Nov 3, 2016 | $0.095 | Quarterly |
Feb 19, 2016 | Jun 1, 2016 | Apr 7, 2016 | $0.095 | Quarterly |
Jul 21, 2015 | Sep 1, 2015 | Aug 13, 2015 | $0.083 | Quarterly |
Feb 27, 2015 | Jun 2, 2015 | Apr 9, 2015 | $0.083 | Quarterly |
Dec 17, 2014 | Mar 3, 2015 | Jan 22, 2015 | $0.083 | Quarterly |
Oct 2, 2014 | Dec 2, 2014 | Nov 5, 2014 | $0.072 | Quarterly |
Jul 31, 2014 | Sep 2, 2014 | Aug 20, 2014 | $0.072 | Quarterly |
Mar 26, 2014 | Jun 2, 2014 | Apr 28, 2014 | $0.072 | Quarterly |
Dec 19, 2013 | Mar 4, 2014 | Jan 30, 2014 | $0.072 | Quarterly |
Sep 12, 2013 | Dec 2, 2013 | Nov 1, 2013 | $0.065 | Quarterly |
Jun 20, 2013 | Sep 2, 2013 | Aug 1, 2013 | $0.07 | Quarterly |
Mar 28, 2013 | Jun 6, 2013 | May 1, 2013 | $0.065 | Quarterly |
Boost your savings and earn 4.35% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.
ⓒ 2024 Financhle. All Rights Reserved.